SCHEMBL1797842

SCHEMBL1797842

O=C(COCC(=O)N1CCN(C2c3ccccc3-c3ccccc32)CC1)Nc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SERPINE1 P05121 2/20 0.68
▸ NPSR1 Q6W5P4 4/20 0.50
▸ MAPT P10636 2/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ CACNA1G O43497 1/20 0.47
▸ POLB P06746 1/20 0.46
▸ G6PD P11413 1/20 0.46
▸ TSHR P16473 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ GPR55 Q9Y2T6 1/20 0.45
▸ CYP3A4 P08684 2/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ GRM5 P41594 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1800112 0.91 SERPINE1 (0.56) SERPINE1NPSR1MAPTL3MBTL1CACNA1G
SCHEMBL1798984 0.81 SERPINE1 (1.00) SERPINE1CACNA1GPOLBG6PD
SCHEMBL1795619 0.81 SERPINE1 (0.69) SERPINE1NPSR1MAPTPOLBG6PD
SCHEMBL29351719 0.80 SERPINE1 (0.98) SERPINE1CACNA1GPOLBG6PD
SCHEMBL1799860 0.80 SERPINE1 (0.98) SERPINE1CACNA1GPOLBG6PD
SCHEMBL1798325 0.80 SERPINE1 (0.69) SERPINE1MAPTPOLBG6PDMEN1
SCHEMBL1797316 0.80 SERPINE1 (0.68) SERPINE1NPSR1MAPTPOLBG6PD
SCHEMBL1796489 0.79 SERPINE1 (0.68) SERPINE1MAPTPOLBG6PDMEN1
SCHEMBL1798356 0.78 SERPINE1 (0.71) SERPINE1MAPTL3MBTL1POLBG6PD
SCHEMBL1797786 0.75 SERPINE1 (0.84) SERPINE1CACNA1GPOLBG6PDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 — — US claimed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 — — US claimed
US-10092537-B2 Use for PAI-1 inhibitor RENASCIENCE CO., LTD. (JP) 2018-10-09 — — US disclosed
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2016-06-09 — — US disclosed
EP-2990057-A1 NOVEL USE FOR PAI-1 INHIBITOR Renascience Co., Ltd. (JP) 2016-03-02 — — EP disclosed
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 — — US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885NPSR1 4264/4885MAPT 4320/4885
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885NPSR1 2115/4885MAPT 2975/4885
US-10092537-B2 Use for PAI-1 inhibitor SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885NPSR1 4248/4885MAPT 4126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback